Understanding why rheumatoid arthritis patient treatment preferences differ by race.
Understanding why rheumatoid arthritis patient treatment preferences differ by race.
复制标题
DOI:
10.1002/art.24338
复制
发表时间:
2009-04-15
影响因子:
--
通讯作者:
Fraenkel, Liana
中科院分区:
文献类型:
--
作者:
Constantinescu, Florina;Goucher, Suzanne;Weinstein, Arthur;Smith, Wally;Fraenkel, Liana
Rheumatoid arthritis (RA) patient preferences may account for some of the variability in treatment amongst different racial groups. How and why treatment preferences differ by race is not well understood. We sought to determine whether Black and White RA patients differ in how they evaluate the specific risks and benefits related to medications. 136 RA patients completed a conjoint analysis interactive computer survey to determine how they valued the specific risks and benefits related to treatment characteristics. We calculated the importance that respondents assigned to each characteristic and the ratio of the importance that patients attached to overall benefit versus overall risk. Subjects having a risk ratio of less than one were classified as being risk averse. The mean age of the study sample was 55 years (range 22–84), 49% were Black and 51% were White. Black subjects assigned the greatest importance to the risk of cancer, whereas White subjects were most concerned with the likelihood of remission and halting radiographic progression. Fifty-two percent of Black subjects were found to be risk averse compared to 12% of the White subjects (p<0.0001). Race remained strongly associated with risk aversion [adjusted odds ratio (95% CI) = 8.4 (3.1 – 23.1)] after adjusting for relevant covariates. Black patients attach greater importance to the risks of toxicity and less importance to the likelihood of benefit than their White counterparts. Effective risk communication and improved understanding of expected benefits may help decrease unwanted variability in healthcare.
登录
查看更多内容
影响因子:
4.7
作者:
Inukai, Keigo;Takahashi, Taiki
通讯作者:
Takahashi, Taiki
影响因子:
39.2
作者:
Andrulis, DP
通讯作者:
Andrulis, DP
影响因子:
5.4
作者:
Dovidio, John F.;Penner, Louis A.;Shelton, J. Nicole
通讯作者:
Shelton, J. Nicole
影响因子:
6.1
作者:
KAHNEMAN, D;TVERSKY, A
通讯作者:
TVERSKY, A
影响因子:
5.6
作者:
Durant, Raegan W.;Davis, Roger B.;Corbie-Smith, Giselle M.
通讯作者:
Corbie-Smith, Giselle M.